Cargando…
The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506635/ https://www.ncbi.nlm.nih.gov/pubmed/34709755 http://dx.doi.org/10.1002/ctm2.527 |
| _version_ | 1784581734080184320 |
|---|---|
| author | Fei, Xiaochen Fan, Liancheng Chen, Wei Chen, Wei Gong, Yiming Du, Xinxing Wang, Yanqing Zhu, Yinjie Pan, Jiahua Wang, Fangqin Zhao, Wanbing Liu, Tongtong Yang, Yining Dong, Baijun Xue, Wei |
| author_facet | Fei, Xiaochen Fan, Liancheng Chen, Wei Chen, Wei Gong, Yiming Du, Xinxing Wang, Yanqing Zhu, Yinjie Pan, Jiahua Wang, Fangqin Zhao, Wanbing Liu, Tongtong Yang, Yining Dong, Baijun Xue, Wei |
| author_sort | Fei, Xiaochen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8506635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85066352021-10-18 The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study Fei, Xiaochen Fan, Liancheng Chen, Wei Chen, Wei Gong, Yiming Du, Xinxing Wang, Yanqing Zhu, Yinjie Pan, Jiahua Wang, Fangqin Zhao, Wanbing Liu, Tongtong Yang, Yining Dong, Baijun Xue, Wei Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-10-12 /pmc/articles/PMC8506635/ /pubmed/34709755 http://dx.doi.org/10.1002/ctm2.527 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Fei, Xiaochen Fan, Liancheng Chen, Wei Chen, Wei Gong, Yiming Du, Xinxing Wang, Yanqing Zhu, Yinjie Pan, Jiahua Wang, Fangqin Zhao, Wanbing Liu, Tongtong Yang, Yining Dong, Baijun Xue, Wei The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
| title | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
| title_full | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
| title_fullStr | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
| title_full_unstemmed | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
| title_short | The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study |
| title_sort | prevalence and clinical implication of rare germline deleterious alterations in chinese patients with prostate cancer: a real‐world multicenter study |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506635/ https://www.ncbi.nlm.nih.gov/pubmed/34709755 http://dx.doi.org/10.1002/ctm2.527 |
| work_keys_str_mv | AT feixiaochen theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT fanliancheng theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT chenwei theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT chenwei theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT gongyiming theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT duxinxing theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT wangyanqing theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT zhuyinjie theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT panjiahua theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT wangfangqin theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT zhaowanbing theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT liutongtong theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yangyining theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT dongbaijun theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT xuewei theprevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT feixiaochen prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT fanliancheng prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT chenwei prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT chenwei prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT gongyiming prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT duxinxing prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT wangyanqing prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT zhuyinjie prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT panjiahua prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT wangfangqin prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT zhaowanbing prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT liutongtong prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT yangyining prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT dongbaijun prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy AT xuewei prevalenceandclinicalimplicationofraregermlinedeleteriousalterationsinchinesepatientswithprostatecancerarealworldmulticenterstudy |